Yoshihiko Sakamoto

Investor

Chief, Corporate Planning Division / 経営企画部主任 at OSAKA University Venture Capital

About

Joined JAIC in 1991 and OUVC investment operations in January 2015. He executed investments in OUVC Fund 1 companies that achieved IPOs (JTEC, Chordia Pharma/Kringle Pharma, Microwave Chemical) and M&A (KOTAI Biotechnologies), and led the AI Samurai M&A exit.

Colleagues at OSAKA University Venture Capital

Akira Morimoto

HR of Investment Company, Investment Division / 投資部 HR担当 at OSAKA University Venture Capital

Akira Uotani

President & CEO / 代表取締役社長 at OSAKA University Venture Capital

Akiyo Ichikawa

Administration Division / 管理部 at OSAKA University Venture Capital

Asano

Capitalist at OSAKA University Venture Capital

Aya Takahashi

Investment Division / 投資部 at OSAKA University Venture Capital

Hiroki Ikuta

Capitalist, Investment Division / 投資部キャピタリスト at OSAKA University Venture Capital

Hiroki Sato

Senior Venture Partner, Investment Division / 投資部シニアベンチャーパートナー at OSAKA University Venture Capital

Kenichi Nobuhara

Corporate Planning Division / 経営企画部 at OSAKA University Venture Capital

Frequently asked questions

Who is Yoshihiko Sakamoto?: Joined JAIC in 1991 and OUVC investment operations in January 2015. He executed investments in OUVC Fund 1 companies that achieved IPOs (JTEC, Chordia Pharma/Kringle Pharma, Microwave Chemical) and M&A (KOTAI Biotechnologies), and led the AI Samurai M&A exit.
Where does Yoshihiko Sakamoto work?: Yoshihiko Sakamoto is Chief, Corporate Planning Division / 経営企画部主任 at OSAKA University Venture Capital.